Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,084 | 818 | 95.5% |
| Debt forgiveness | $520.00 | 1 | 3.3% |
| Education | $192.79 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,758 | 175 | $0 (2024) |
| Amgen Inc. | $2,433 | 121 | $0 (2024) |
| Janssen Biotech, Inc. | $1,195 | 70 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $981.89 | 61 | $0 (2024) |
| PFIZER INC. | $935.17 | 57 | $0 (2024) |
| UCB, Inc. | $920.17 | 38 | $0 (2024) |
| Lilly USA, LLC | $776.00 | 42 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $629.05 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $562.00 | 32 | $0 (2024) |
| Welch Allyn | $520.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,340 | 96 | Amgen Inc. ($417.02) |
| 2023 | $3,028 | 148 | AbbVie Inc. ($769.65) |
| 2022 | $2,705 | 145 | ABBVIE INC. ($590.76) |
| 2021 | $2,933 | 140 | Welch Allyn ($520.00) |
| 2020 | $2,038 | 106 | Amgen Inc. ($434.53) |
| 2019 | $1,451 | 80 | AbbVie, Inc. ($209.64) |
| 2018 | $223.78 | 11 | Lilly USA, LLC ($53.76) |
| 2017 | $1,077 | 98 | PFIZER INC. ($356.84) |
All Payment Transactions
824 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $25.81 | General |
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | SANOFI-AVENTIS U.S. LLC | KEVZARA (Biological) | Education | In-kind items and services | $79.00 | General |
| Category: Rheumatology | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Rare Disease | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Immunology | ||||||
| 11/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/05/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Rheumatology | ||||||
| 11/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Bone Health | ||||||
| 10/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 305 | 1,666 | $173,651 | $58,003 |
| 2022 | 12 | 341 | 2,060 | $210,074 | $69,809 |
| 2021 | 14 | 362 | 1,808 | $176,625 | $65,121 |
| 2020 | 11 | 248 | 400 | $66,132 | $24,966 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,200 | $60,000 | $22,233 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 197 | $52,280 | $18,831 | 36.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 50 | $18,505 | $6,229 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,238 | $3,109 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $6,322 | $2,086 | 33.0% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 34 | 66 | $8,712 | $1,756 | 20.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 28 | $6,440 | $1,627 | 25.3% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 16 | 26 | $3,380 | $697.37 | 20.6% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 11 | 19 | $2,280 | $496.98 | 21.8% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 14 | 14 | $1,960 | $446.89 | 22.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $1,595 | $330.66 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 14 | $2,940 | $157.78 | 5.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 16 | 1,500 | $75,000 | $25,830 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 228 | $60,245 | $21,618 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 71 | $26,137 | $9,409 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $11,237 | $4,442 | 39.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 19 | 40 | $9,200 | $2,499 | 27.2% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 43 | 80 | $10,560 | $2,302 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,132 | $1,774 | 34.6% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 14 | 26 | $3,120 | $745.25 | 23.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 12 | 17 | $2,040 | $431.53 | 21.2% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 13 | 17 | $2,212 | $415.29 | 18.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 23 | $4,830 | $256.70 | 5.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 14 | 18 | $360.00 | $87.18 | 24.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 229 | $44,965 | $22,573 | 50.2% |
About Dr. Deepika Arora, MBBS
Dr. Deepika Arora, MBBS is a Internal Medicine healthcare provider based in League City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1053689455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepika Arora, MBBS has received a total of $15,797 in payments from pharmaceutical and medical device companies, with $2,340 received in 2024. These payments were reported across 824 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($15,084).
As a Medicare-enrolled provider, Arora has provided services to 1,256 Medicare beneficiaries, totaling 5,934 services with total Medicare billing of $217,899. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology, Rheumatology
- Location League City, TX
- Active Since 12/13/2011
- Last Updated 08/01/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053689455
Products in Payments
- RINVOQ (Biological) $1,713
- Enbrel (Biological) $1,631
- XELJANZ (Drug) $828.67
- TREMFYA (Drug) $823.46
- Cimzia (Drug) $805.23
- TALTZ (Drug) $722.24
- COSENTYX (Biological) $703.13
- ACTHAR (Biological) $679.83
- BENLYSTA (Biological) $562.00
- None (Device) $520.00
- SAPHNELO (Biological) $511.55
- LUPKYNIS (Drug) $510.38
- EVENITY (Biological) $506.96
- SKYRIZI (Biological) $452.72
- ORENCIA (Biological) $341.94
- KEVZARA (Biological) $340.55
- Rituxan (Biological) $284.25
- Humira (Biological) $218.24
- SIMPONI ARIA (Biological) $204.28
- COSENTYX (Drug) $180.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in League City
Dr. David Washington, Md, MD
Internal Medicine — Payments: $3,491
Israa Ali
Internal Medicine — Payments: $3,171
Jason Gukhool, M.d, M.D
Internal Medicine — Payments: $2,510
Julia Zhang
Internal Medicine — Payments: $2,129
Joanna Nowak, Md, MD
Internal Medicine — Payments: $719.13
Cindy Chan, M.d, M.D
Internal Medicine — Payments: $633.15